Pancreatic cancer, known for its silent but formidable presence, ranks among the deadliest forms of cancer globally. Despite being the twelfth most diagnosed cancer, it holds the seventh highest fatality rate, with a mere 5 to 10 percent 5-year survival rate. These grim statistics underscore the urgent need for innovative treatments, prompting a closer examination of advancements in the field.